Sacroiliac Joint Fusion Market Projected to Expand at a 20.2% CAGR by 2032

The global sacroiliac joint fusion market is anticipated to be worth US$ 620 million in 2022 and US$ 3,900 million in 2032. From 2022 to 2032, the market is predicted to increase at a CAGR of 20.2%.

The market's growth can be attributed to the healthcare industry's rapid technological advancement and the growing need for less invasive surgical treatments.

Sacroiliac joint fusion is one of the most recent and effective procedures for treating sacroiliac discomfort, and it is frequently performed by orthopedic surgeons at Yale Medicine.

Sacroiliac joint fusion (SIJF) has gained in popularity as less invasive surgical procedures have become more widely available. This has resulted in an explosion of novel medical gadgets utilized for SIJF. The increasing number of vehicle accidents resulting in joint displacement is expected to boost demand for MIS sacroiliac joint fusion treatment. The sacroiliac joint has been identified as the etiology of chronic low back pain in approximately 15 to 30% of patients.

Get Free Sample Report to Grow Your Profit Margin – https://www.factmr.com/connectus/sample?flag=S&rep_id=7164

According to Fact.MR, North America is expected to account for 42% of sales in 2022 and beyond. This dominant market share is attributed to the presence of leading companies, advanced healthcare infrastructure, and expanding reimbursement options. Additionally, the rising incidence of joint pain is creating further growth opportunities.

Data from the National Center for Biotechnology Information shows that the annual prevalence of low back pain in the United States ranges between 15% and 45%. To address the burden of this condition and improve patient outcomes, significant efforts have been made to understand its various causes. Among these, the sacroiliac (SI) joint has gained increased attention as a contributor to back pain, with estimates indicating that 15% to 30% of low back pain cases are associated with the SI joint.

Region-wise Analysis

Fact.MR estimates that North America will contribute to 42% of market revenue in 2022 and beyond. This substantial market share is attributed to the presence of leading companies, advanced healthcare infrastructure, and expanding reimbursement policies. Additionally, the rising prevalence of joint pain is further enhancing growth opportunities in the region.

According to the National Center for Biotechnology Information, the annual prevalence of low back pain in U.S. adults ranges between 15% and 45%. To address the burden of this condition and improve patient outcomes, significant efforts have been made to understand its underlying causes. The sacroiliac (SI) joint, in particular, has gained increased focus as a contributor to back pain, with estimates suggesting that 15% to 30% of low back pain cases can be attributed to issues with the SI joint.

Category-wise Insights

According to Fact.MR, the degenerative sacroiliitis segment is projected to account for 39% of market revenue in 2022 and beyond. This growth is fueled by the high prevalence of degenerative sacroiliitis and advancements in diagnostic and treatment capabilities.

Meanwhile, sacroiliac joint fusion for trauma-related injuries is anticipated to gain significant momentum during the forecast period. The use of SI joint fusion systems for trauma indications has recently received FDA approval, contributing to the rapid expansion of this segment.

Sacroiliac joint fusion procedures are expected to account for 40% of revenue in 2022. The increasing demand for minimally invasive operations due to the accompanying benefits, such as smaller incisions, less pain and scarring, and faster recovery times, is the primary reason for this segment's high share.

As patients seek trauma-free surgeries, hospitals and other healthcare settings are prioritizing minimally invasive surgical solutions, which lessen discomfort.

Key Segments Covered in the Sacroiliac Joint Fusion Market Report

• By Indication :

  • Joint Fusion for Degenerative Sacroiliitis
  • Joint Fusion for Sacral Disruption
  • Sacroiliac Joint Fusion for Trauma

• By Treatment Type :

  • Sacroiliac Joint Fusion Surgery
    • Surgery Type
      • Minimally Invasive Sacroiliac Joint Fusion Surgery
      • Open Sacroiliac Joint Fusion Surgery
    • Approach
      • Dorsal Sacroiliac Joint Fusion
      • Anterior Sacroiliac Joint Fusion
    • Product
      • Sacroiliac Joint Fusion Implants
      • Sacroiliac Joint Fusion Accessories
  • Sacroiliac Joint Fusion Injections
    • Diagnosis
    • Treatment
  • RF Sacroiliac Joint Fusion Ablation

• By End User :

  • Sacroiliac Joint Fusion in Hospitals
  • Sacroiliac Joint Fusion in Ambulatory Surgical Centers
  • Sacroiliac Joint Fusion for Other End Users (Specialty Centers and Research & Academic Institutes)

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com